EasyCardiologyHeart failure with reduced ejection fractionau-amcau-racp
A 70-year-old man with known ischaemic cardiomyopathy (LVEF 30%) is clinically euvolaemic in your clinic. He has NYHA class II symptoms but no current oedema. Which medication combination forms the cornerstone of disease-modifying therapy in such heart failure with reduced ejection fraction?